Status:
COMPLETED
Exacerbation of Erythema Following PDT in Patients With Probable Capillary Malformation-Arteriovenous Malformation Syndrome: Retrospective Analysis of Ultrasound and Clinical Characteristics.
Lead Sponsor:
Second Affiliated Hospital of Xi'an Jiaotong University
Conditions:
Probable Capillary Malformation-Arteriovenous Malformation Syndrome
Eligibility:
All Genders
1+ years
Brief Summary
This study aims to reduce the misdiagnosis rate of PWSs and improve the diagnosis of CM-AVM using ultrasound. Furthermore, we seek to provide more evidence-based recommendations for the treatment of p...
Detailed Description
Background: Exacerbation of erythema following photodynamic therapy (PDT) in patients with probable capillary malformation-arteriovenous malformation (CM-AVM) syndrome, may be attributed to misdiagnos...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who were greater than or equal to 1 year old at the time of their first HMME-PDT treatment.
- Patients who experiencing exacerbation of clinical symptoms, such as darker coloration than before treatment.
- Patients who have undergone one or more HMME-PDT treatments. ④ Patients with complete basic information and treatment-related information.
Exclusion
Key Trial Info
Start Date :
March 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06985563
Start Date
March 1 2024
End Date
June 1 2024
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 710004